Coronary CT Angiography in a Patient with Tachycardia and Frequent Premature Atrial Contractions

Neither prospective triggering nor a high heart rate is automatically disqualifying, but the irregular rhythm drives the choice.

• Prospective step-and-shoot works by acquiring a narrow window at a fixed diastolic or systolic delay. With frequent premature atrial contractions, an ectopic beat resets the timing, so whole slabs can be acquired in the wrong phase and produce misregistration or gaps that may be unreconstructable.
• Retrospective helical gating with ECG-based tube current modulation acquires the whole cardiac volume, so beats affected by ectopy can be edited out and the data re-binned; multiple phases allow choosing the quietest diastolic or systolic phase per vessel.
• First, though, treat the cause: caffeine, anxiety and pain are all modifiable. Delay 20–30 minutes, coach breathing, give a beta-blocker if appropriate, and reassess. If the rate falls below about 65 beats/min and the rhythm becomes regular, a prospective protocol gives the same diagnostic information at a fraction of the dose.
• If ectopy persists, prospective triggering is still possible with widened padding and arrhythmia editing, but the risk of a nondiagnostic study is higher, so discuss that with the patient beforehand.

Beta-blockade is reasonable here, but it should be given as a monitored, titrated intervention rather than a reflex.

• Contraindications to check first: asthma or severe reactive airway disease, second- or third-degree heart block, decompensated heart failure, systolic blood pressure under about 100 mmHg, or resting bradycardia. She has none, and her pressure is 138/84.
• Regimen: intravenous metoprolol in 5 mg increments every 3–5 minutes to a maximum of 15 mg, with continuous ECG and blood pressure monitoring and a physician available. Reassess after each dose; target roughly below 65 beats/min for a 64-row scanner.
• Why it may not be enough: caffeine can blunt the effect, so allowing 30 minutes before redosing helps, and beta-blockade slows the sinus rate but does not abolish premature atrial contractions. If rate control succeeds but ectopy persists, the acquisition strategy - not more drug - is what needs changing.
• If beta-blockade fails or is contraindicated: a calcium channel blocker or ivabradine can be considered under physician direction; document the response and any adverse effect.

Give nitroglycerin only after a documented contraindication check, and be honest about the limits of the study.

• Nitroglycerin: sublingual 0.4 mg (some protocols use 0.8 mg) 3–5 minutes before acquisition dilates the coronaries and improves evaluation of small distal vessels. It is contraindicated within 24 hours of sildenafil or vardenafil and within 48 hours of tadalafil, and should be avoided with systolic pressure below about 100 mmHg or severe aortic stenosis. Confirm and record the answer.
• If the study remains nondiagnostic: do not simply repeat the acquisition and add dose. Report the segments that are evaluable, state clearly which are not, and explain why - ectopy, motion, or poor opacification.
• Counsel the patient and referrer: a nondiagnostic coronary CTA is not a negative study. Discuss alternatives such as stress imaging or invasive angiography if pretest probability is high, and note that a second attempt after better rate control on an outpatient basis is an option if clinical urgency allows.